18th Annual Pain Therapeutics Conference
In-Person Event
May 21 - 22, 2018
London, England, GB
OVERVIEW
18th Annual Pain Therapeutics conference is organized by SMi Group and will be held during May 21 - 22, 2018 at Holiday Inn Kensington Forum, London, England, United Kingdom.
The target audience for this medical event is Chief Executive Officer, Chief Scientific Officers, Chief Medical Officers, Managing Directors, CEO, Head of Department, Principal Research Scientists, Clinical lead, Clinical Operations in the following fields:
• Pain and Migraine
• Inflammation
• Chronic Pain
• Neuropathic Pain
• Analgesic pre-clinical development
• Anaesthesia and Pain Management
• CNS clinical trials
• Ion Channel Pharmacology
• Pharmacology Intelligence
• Translational science
• Drug development
• Exploratory development
Analgesics are among the most commonly prescribed drugs in the world and yet, finding novel targets and mechanisms that may elevate hard to treat pain is becoming more difficult. After nearly 20 years of successful Pain Therapeutics conferences, join us for the conference in May to explore novel targets for pain therapeutics, new translational approaches and pipeline drug development from the leading pharma companies in pain management.
We have worked hard to bring together an elite speaker panel to educate and inspire our delegates through the exploration of innovative approaches and novel targets in analgesic medicine.
Attendees will be able to network with industry experts from leading pharma companies, biotech and academics to name but a few. If you want to discover the future of pain therapeutics and be a part of the conversation.
Conference Highlights :
• Explore the possibilities of DNA-based, disease modifying treatments for painful diabetic neuropathy with ViroMed
• Overcome the challenges of patient recruitment and the placebo response with Novartis
• Learn how AstraZeneca and Eli Lilly are targeting ion channels to reduce pain
• Get involved in round table discussions on chronic pain and depression, the opioid crisis, and alternatives to animal models
• Listen to Centrexion, Amgen, Janssen, Nektar Therapeutics and Grunenthal discuss the current industry outlook.
The upcoming Pain Therapeutics conference moves away from well discussed topics such as opioid dependence and animal models and focuses on the most exciting current research, opinions, novel targets and mechanisms and advances in the field of analgesic medicine.
Prices:
Book by 31st January to save £400: GBP 1099.00
Book by 28th February and save £200: GBP 1299.00
Book by 29th March and save £100: GBP 1399.00
Standard: GBP 1499.00
Speakers: Amgen, Aptinyx, AstraZeneca, Cara Therapeutics, Centrexion Therapeutics Corp., Danish Headache Centre, Eli Lilly, Flexion Therapeutics, Grunenthal, Innopain, J & JPRD, Lotus Clinical Research, Llc, Mundipharma Research GmbH & Co. KG, Nektar Therapeutics, Novartis Pharmaceuticals, phd pharma design, Prescient Healthcare Group & Viromed
Additional details will be posted as soon as they are available.
The target audience for this medical event is Chief Executive Officer, Chief Scientific Officers, Chief Medical Officers, Managing Directors, CEO, Head of Department, Principal Research Scientists, Clinical lead, Clinical Operations in the following fields:
• Pain and Migraine
• Inflammation
• Chronic Pain
• Neuropathic Pain
• Analgesic pre-clinical development
• Anaesthesia and Pain Management
• CNS clinical trials
• Ion Channel Pharmacology
• Pharmacology Intelligence
• Translational science
• Drug development
• Exploratory development
Analgesics are among the most commonly prescribed drugs in the world and yet, finding novel targets and mechanisms that may elevate hard to treat pain is becoming more difficult. After nearly 20 years of successful Pain Therapeutics conferences, join us for the conference in May to explore novel targets for pain therapeutics, new translational approaches and pipeline drug development from the leading pharma companies in pain management.
We have worked hard to bring together an elite speaker panel to educate and inspire our delegates through the exploration of innovative approaches and novel targets in analgesic medicine.
Attendees will be able to network with industry experts from leading pharma companies, biotech and academics to name but a few. If you want to discover the future of pain therapeutics and be a part of the conversation.
Conference Highlights :
• Explore the possibilities of DNA-based, disease modifying treatments for painful diabetic neuropathy with ViroMed
• Overcome the challenges of patient recruitment and the placebo response with Novartis
• Learn how AstraZeneca and Eli Lilly are targeting ion channels to reduce pain
• Get involved in round table discussions on chronic pain and depression, the opioid crisis, and alternatives to animal models
• Listen to Centrexion, Amgen, Janssen, Nektar Therapeutics and Grunenthal discuss the current industry outlook.
The upcoming Pain Therapeutics conference moves away from well discussed topics such as opioid dependence and animal models and focuses on the most exciting current research, opinions, novel targets and mechanisms and advances in the field of analgesic medicine.
Prices:
Book by 31st January to save £400: GBP 1099.00
Book by 28th February and save £200: GBP 1299.00
Book by 29th March and save £100: GBP 1399.00
Standard: GBP 1499.00
Speakers: Amgen, Aptinyx, AstraZeneca, Cara Therapeutics, Centrexion Therapeutics Corp., Danish Headache Centre, Eli Lilly, Flexion Therapeutics, Grunenthal, Innopain, J & JPRD, Lotus Clinical Research, Llc, Mundipharma Research GmbH & Co. KG, Nektar Therapeutics, Novartis Pharmaceuticals, phd pharma design, Prescient Healthcare Group & Viromed
Additional details will be posted as soon as they are available.
KEY DATES
21 May, 2018
Event Start Date
22 May, 2018
Event End Date
SPECIALITIES
Pain ManagementSUGGESTED HOTELS
CONFERENCE VENUE
Holiday Inn Kensington ForumQuick Links